SynAct Pharma AB (STO:SYNACT)

SynAct Pharma AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 21, 2025	Dec 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	875	417	314	2,416	3,703	1,081
Market Cap Growth	32.69%	32.69%	-87.00%	-34.75%	242.52%	809.57%
Enterprise Value	815	380	286	2,364	3,659	1,055
Last Close Price	17.85	8.96	8.75	80.76	140.30	43.65
PB Ratio	3.87	1.95	1.78	19.10	177.45	68.14
P/TBV Ratio	7.00	7.00	13.07	19.10	177.45	68.14
Debt / Equity Ratio	0.01	0.01	0.00	0.02	0.15	-
Quick Ratio	2.66	2.66	3.00	8.19	2.25	3.67
Current Ratio	3.30	3.30	3.01	9.34	2.27	3.73
Return on Equity (ROE)	-42.22%	-42.22%	-142.59%	-134.62%	-377.30%	-189.27%
Return on Assets (ROA)	-22.56%	-22.56%	-46.86%	-72.92%	-159.60%	-82.32%
Return on Capital (ROIC)	-28.63%	-28.63%	-56.87%	-86.51%	-240.29%	-139.39%
Earnings Yield	-9.42%	-19.77%	-68.71%	-4.11%	-1.87%	-2.46%
FCF Yield	-21.40%	-21.40%	-31.89%	-4.86%	-1.76%	-3.07%
Buyback Yield / Dilution	-21.55%	-21.55%	-17.90%	-6.72%	-19.95%	-43.06%
Total Shareholder Return	-21.55%	-21.55%	-17.90%	-6.72%	-19.95%	-43.06%

Source: S&P Capital IQ. Standard template. Financial Sources.